Unless other areas of biphasic or monophasic synovial sarcoma are seen, and because they usually show membranous CD99 immunoreactivity, immunohistochemical distinction of poorly differentiated synovial sarcoma from EFT may be difficult. This evidence concerns the gene CD99 and synovial sarcoma.